ABT EBITDA Growth
Abbott Laboratories · EBITDA Growth
ABT EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-2.46%period ending
ABT TTM EBITDA YoY % (18.91% → -2.46%)
Year-over-year change
High-resolution chart · PNG
ABT ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -2.463% | |
| 3.9034% | |
| 10.7624% | |
| 10.3761% | |
| 11.3968% | |
| 6.8149% | |
| 2.1594% | |
| 6.3165% | |
| 3.835% | |
| -2.5773% | |
| -10.7924% | |
| -22.0456% | |
| -26.8614% | |
| -16.499% | |
| -2.2288% | |
| 5.4629% | |
| 23.3909% | |
| 24.7811% | |
| 35.055% | |
| 57.3948% | |
| 48.8559% | |
| 27.2345% | |
| 13.8323% | |
| 0.2064% | |
| 1.1779% | |
| 14.1767% | |
| 14.9564% | |
| 18.7653% | |
| 14.7786% | |
| 21.9828% | |
| 12.6761% | |
| 16.4674% | |
| 51.9839% | |
| 37.1807% | |
| 108.7521% | |
| 84.5571% | |
| 7.2713% | |
| 1.537% | |
| -39.2902% | |
| -37.0048% | |
| -17.5647% | |
| -7.4667% | |
| 14.3332% | |
| 15.5326% | |
| 19.0497% | |
| 22.8292% | |
| 7.9274% | |
| -4.1739% | |
| -11.4847% | |
| -28.3347% | |
| -27.4934% | |
| -32.6355% | |
| -33.0383% | |
| -36.8979% | |
| -38.6162% | |
| -25.4688% | |
| -25.427% | |
| -8.4324% | |
| -1.3228% | |
| -0.9415% | |
| -3.3253% | |
| -4.7143% | |
| -9.3101% | |
| -13.0344% | |
| -0.0447% | |
| -1.3778% | |
| 13.3386% | |
| 27.5822% | |
| 26.7921% | |
| 38.281% | |
| 34.4423% | |
| 33.8326% | |
| 29.142% | |
| 34.4164% | |
| 26.1325% | |
| 11.7834% | |
| 10.9867% | |
| -10.7125% | |
| -11.1148% | |
| -5.9633% | |
| -10.0699% | |
| 0.4515% | |
| 4.9819% | |
| 3.2368% | |
| 10.5936% | |
| 27.943% | |
| 24.0069% | |
| 32.3482% | |
| 24.3181% | |
| -6.8842% | |
| -8.4596% | |
| -14.7797% | |
| -10.1705% | |
| 1.3098% | |
| 9.6242% | |
| 11.0721% | |
| 9.4496% | |
| 9.1861% | |
| 3.8894% | |
| 4.6796% |